News

All Releases
Tandem Diabetes Care to Provide All t:slim X2 Insulin Pump Features Approved in 2018 to Users at No Cost and Expands Existing Dexcom Welcome Offer for Animas Customers
Oct 24, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it will make any new features approved for the t:slim X2™ Insulin Pump by the U.S.
Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call
Oct 16, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its third quarter 2017 results after the financial markets close on Thursday, October 26, 2017
Tandem Diabetes Care Announces Pricing of $16.2 Million Underwritten Public Offering of Common Stock and Warrants
Oct 13, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of (i) 4,630,000 shares of its common stock, (ii)
Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock, Series A Warrants and Series B Warrants
Oct 12, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it is proposing to offer and sell shares of its common stock, Series A warrants and Series
Tandem Diabetes Care Announces Approval of Reverse Stock Split
Oct 09, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) previously announced that a proposal was approved at its Special Meeting of Stockholders, held September 7, 2017 , authorizing its Board of Directors to amend the Company's certificate of incorporation to effect a reverse
Tandem Diabetes Care Reports Rapid Uptake and High Satisfaction Scores For t:slim X2 Insulin Pump Remote Software Update Following Launch of CGM Integration
Sep 28, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that one-third of t:slim X2™ Pump users have already updated their pumps via personal computer
Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
Aug 28, 2017
‒ Software Update Available for Current t:slim X2 Pump Users Via Personal Computer ‒ SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced U.S.
Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps
Aug 24, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,737,656 titled "Integration of Infusion Pump with Remote
Tandem Diabetes Care Announces Launch of t:lock Connector for its Insulin Pump Cartridges and Infusion Sets
Aug 23, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the launch of the t:lock™ Connector for its insulin pump cartridges and infusion sets.
Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with Predictive Low Glucose Suspend (PLGS)
Aug 15, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced enrollment of the first patients in an at-home pivotal trial for its t:slim X2™ Insulin Pump
Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control
Aug 08, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,715,327 titled "Preventing Inadvertent Changes in Ambulatory
Tandem Diabetes Care to Present at the 2017 Wedbush PacGrow Healthcare Conference
Aug 01, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the 2017 Wedbush
Tandem Diabetes Care Reports Second Quarter 2017 Financial Results
Jul 27, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended June 30, 2017 .
Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release and Conference Call
Jul 13, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2017 results after the financial markets close on Thursday, July 27, 2017 .
Tandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial
Jun 12, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today presented results from a feasibility study for its predictive low glucose suspend (PLGS) algorithm,
Tandem Diabetes Care Reports First Quarter 2017 Financial Results
Apr 27, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended March 31, 2017 .
Tandem Diabetes Care to Present at the Deutsche Bank 42nd Annual Health Care Conference
Apr 19, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the Deutsche Bank 42
Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release and Conference Call
Apr 13, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its first quarter 2017 results after the financial markets close on Thursday, April 27, 2017 .
Tandem Diabetes Care Launches New t:connect Diabetes Management Application Portal for Healthcare Providers
Apr 11, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the launch of the t:connect ® HCP Portal. The portal is an extension of the company's Mac- and
Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock
Mar 23, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock at a
Displaying 41 - 60 of 166